Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on E
Target Price
The average target price of ZTS is 160 and suggests 37% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell